Medivizor

Title of notification

Here comes the notification
X
 
icon
benign prostatic hyperplasia | Research | 10 pages | source: International journal of clinical practice | Added Dec 18, 2018

Is nocturia more bothersome than daytime urinary symptoms?

This study examined the differences in quality of life for patients with nocturia compared to those with daytime urinary symptoms only. This study found that patients with nocturia had a lower quality of life than patients with daytime symptoms only.

icon
hypertension | Research | 10 pages | source: Journal of the American College of Cardiology | Added Dec 17, 2018

Blood pressure management for patients with atrial fibrillation

This study investigated the target blood pressure (BP) levels for patients with atrial fibrillation (AF). They found that patients with AF and BP greater than 130/80 mmHg have a higher risk of cardiovascular events.

icon
icon
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Investigative and clinical urology | Added Dec 16, 2018

Evaluating photo-selective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia

This study aimed to evaluate the use of photo-selective vaporization of the prostate (PVP) in treating benign prostatic hyperplasia (BPH). This study found that PVP is a safe and effective procedure for the treatment of BPH.

icon
hypertension | Research | 10 pages | source: Journal of the American College of Cardiology | Added Dec 14, 2018

Left atrial appendage exclusion (LAAE) – can it reduce blood pressure in patients with atrial fibrillation?

This study investigated if left atrial appendage exclusion (LAAE) reduced blood pressure (BP) in patients with atrial fibrillation (AF). They found that this procedure reduced BP in patients with AF.

icon
icon
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Dec 13, 2018

Effectiveness of dutasteride and solifenacin used to treat benign prostatic hyperplasia

This study aimed to investigate the effects of combining dutasteride (Avodart) and solifenacin (Vesicare) on sexual function in men being treated for benign prostatic hyperplasia (BPH). This study found that the combination of dutasteride and solifenacin does not alter sexual function for men with BPH.

icon
hypertension | Research | 10 pages | source: The American journal of cardiology | Added Dec 12, 2018

Strict blood pressure management and cardiovascular disease risk: results from the SPRINT study

This study investigated if strict blood pressure (BP) management improves cardiovascular disease (CVD) risk. 

They found that strict BP control reduced the risk of atherosclerotic CVD.

icon
icon
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: International journal of urology: official journal of the Japanese Urological Association | Added Dec 11, 2018

Can Silodosin ease Benign Prostatic Hyperplasia symptoms?

This study looked at using Silodosin (Rapaflo) to treat lower urinary tract symptoms caused by Benign Prostatic Hyperplasia (BPH). It concluded that silodosin is an effective treatment for lower urinary tract symptoms. 

icon
hypertension | Research | 10 pages | source: European Heart Journal | Added Dec 10, 2018

Does high blood pressure increase the risk of aortic valve disease?

This study investigated if elevated blood pressure increases the risk of aortic valve disease (AVD).

They found that increasing blood pressure was associated with an increased risk of AVD.

icon
icon
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added Dec 09, 2018

Preserved sexual function with water vapor thermal therapy for benign prostatic hyperplasia

This study aimed to investigate the effect on sexual function of water vapor therapy for the treatment of urinary symptoms from benign prostatic hyperplasia (BPH). This study found that water vapor therapy is effective and does not affect sexual function for men with BPH. 

icon
icon
hypertension | Research | Treatment | 10 pages | source: Vascular health and risk management | Added Dec 07, 2018

Perindopril and amlodipine – can this combination prevent organ damage in hypertension?

This study investigated the effects of the drug combination perindopril and amlodipine (PEAM) on organ damage in patients with hypertension with and without ischemic heart disease (IHD).

They found that PEAM was effective in reducing blood pressure and organ damage in these patients.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?